Both Pfizers oral drug danuglipron and Novo Nordiskss semaglutide (Ozempic brand for diabetes, Wegovy brand for weight loss) mimic glucagon-like peptide-1 (GLP-1), a gut hormone that signals the brain when a person is full
As of May 2026, BPC-157 remains on the FDAs Category 2 restricted list, pending advisory-committee review
However, the unique structure and chirality of fucoxanthin are unstable
Obesity is associated with dysregulation of the HPA axis, and some studies suggest that individuals with excess weight may have altered cortisol metabolism
That makes Lose It a strong general food tracker, but it is not positioned in official listings as a dedicated GLP-1 companion for shot day, injection sites, side effects, medication-level context, Journey Cards, or Capy-style daily support